Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024

8/5/24 9:00:00 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $MOVE alert in real time by email

Conference Call at 2:00 PM PT/ 5:00 PM ET

PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, today announced that it will report second quarter 2024 financial and operating results on Wednesday, August 14, 2024, after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at 2:00 pm PT/5:00 pm ET.

Attendees can access the live webcast here or on the investors section of Movano Health's website at https://ir.movano.com. The conference call can be accessed by dialing 1-877-407-0989 (domestic), or 1 201-389-0921 (international). Attendees can also use the Call Me link where they will be dialed into the conference call instantly on the number provided with no hold time. An archived webcast will be available on Movano Health's website approximately one hour after the completion of the event and for two years thereafter.

About Movano Health

Founded in 2018, Movano Inc. (NASDAQ:MOVE) dba Movano Health, maker of the Evie Ring (www.eviering.com), is developing a suite of purpose-driven healthcare solutions to bring medical-grade data to the forefront of wearables. Featuring modern and flexible form factors, Movano Health's devices offer an innovative approach to delivering trusted data to both customers and enterprises, capturing a comprehensive picture of an individual's health data and uniquely translating it into personalized and intelligent insights.

Movano Health's proprietary technologies and wearable medical device solutions will soon enable the use of data as a tool to proactively monitor and manage health outcomes across a number of patient populations that exist in healthcare. For more information on Movano Health, visit https://movanohealth.com/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/movano-health-to-report-second-quarter-2024-financial-results-on-wednesday-august-14-2024-302213885.html

SOURCE Movano

Get the next $MOVE alert in real time by email

Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024

Chat with this insight

Recent Analyst Ratings for
$MOVE

$MOVE
Press Releases

Fastest customizable press release news feed in the world

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

Movano Health's Board of Directors Initiates Process to Maximize Shareholder Value

Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements

$MOVE
Financials

Live finance-specific insights

Movano Health Reports Q3 2024 Financial Results and Provides Business Update

Movano Health Reports Q2 2024 Financial Results and Provides Business Update

Movano Health Provides Progress Update on EvieMED Regulatory Filing

$MOVE
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Caballero Ruben bought 22,000 shares, increasing direct ownership by 38% to 80,200 units (SEC Form 4)

Fairbairn Emily bought 4,690,000 shares (SEC Form 4)

Cogan Jeremy bought 45,000 shares, increasing direct ownership by 6% to 780,649 units (SEC Form 4)

$MOVE
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Caballero Ruben was granted 43,605 shares, increasing direct ownership by 816% to 48,952 units (SEC Form 4)

CFO Cogan Jeremy was granted 62,986 shares, increasing direct ownership by 121% to 115,028 units (SEC Form 4)

Chief Executive Officer Mastrototaro John was granted 77,521 shares, increasing direct ownership by 399% to 96,964 units (SEC Form 4)

$MOVE
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Movano Inc.

SEC Form SC 13G/A filed by Movano Inc. (Amendment)

SEC Form SC 13G filed by Movano Inc.

$MOVE
SEC Filings

Movano Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form NT 10-Q filed by Movano Inc.

Movano Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events

Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024

Chat with this insight

Recent Analyst Ratings for $MOVE

$MOVE Press Releases

Fastest customizable press release news feed in the world

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

Movano Health's Board of Directors Initiates Process to Maximize Shareholder Value

Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements

$MOVE Financials

Live finance-specific insights

Movano Health Reports Q3 2024 Financial Results and Provides Business Update

Movano Health Reports Q2 2024 Financial Results and Provides Business Update

Movano Health Provides Progress Update on EvieMED Regulatory Filing

$MOVE Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Caballero Ruben bought 22,000 shares, increasing direct ownership by 38% to 80,200 units (SEC Form 4)

Fairbairn Emily bought 4,690,000 shares (SEC Form 4)

Cogan Jeremy bought 45,000 shares, increasing direct ownership by 6% to 780,649 units (SEC Form 4)

$MOVE Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Caballero Ruben was granted 43,605 shares, increasing direct ownership by 816% to 48,952 units (SEC Form 4)

CFO Cogan Jeremy was granted 62,986 shares, increasing direct ownership by 121% to 115,028 units (SEC Form 4)

Chief Executive Officer Mastrototaro John was granted 77,521 shares, increasing direct ownership by 399% to 96,964 units (SEC Form 4)

$MOVE Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Movano Inc.

SEC Form SC 13G/A filed by Movano Inc. (Amendment)

SEC Form SC 13G filed by Movano Inc.

$MOVE SEC Filings

Movano Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form NT 10-Q filed by Movano Inc.

Movano Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events

Recent Analyst Ratings for
$MOVE

$MOVE
Press Releases

$MOVE
Financials

$MOVE
Insider Purchases

$MOVE
Insider Trading

$MOVE
Large Ownership Changes

$MOVE
SEC Filings